Oxford Immunotec Global PLC
DelistedCIK 1586049fmd_02V48S4WHB4T8TZXCFKZM1PBB5Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2012 to Sep 30, 2020, 32 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading